Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $3.45 billion. The enterprise value is $1.58 billion.
Important Dates
The next confirmed earnings date is Wednesday, August 6, 2025, before market open.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 254.36 million shares outstanding. The number of shares has increased by 19.35% in one year.
| Current Share Class | 218.85M |
| Shares Outstanding | 254.36M |
| Shares Change (YoY) | +19.35% |
| Shares Change (QoQ) | +23.26% |
| Owned by Insiders (%) | 3.44% |
| Owned by Institutions (%) | 73.13% |
| Float | 206.41M |
Valuation Ratios
The trailing PE ratio is 29.40.
| PE Ratio | 29.40 |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| Forward PS | 0.30 |
| PB Ratio | 2.58 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | 2.90 |
| P/OCF Ratio | 2.83 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.89, with an EV/FCF ratio of 1.32.
| EV / Earnings | 12.78 |
| EV / Sales | 0.16 |
| EV / EBITDA | 7.89 |
| EV / EBIT | 9.34 |
| EV / FCF | 1.32 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.27.
| Current Ratio | 0.91 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.68 |
| Debt / FCF | 0.30 |
| Interest Coverage | 7.09 |
Financial Efficiency
Return on equity (ROE) is 10.47% and return on invested capital (ROIC) is 6.82%.
| Return on Equity (ROE) | 10.47% |
| Return on Assets (ROA) | 2.06% |
| Return on Invested Capital (ROIC) | 6.82% |
| Return on Capital Employed (ROCE) | 9.96% |
| Revenue Per Employee | $4.20M |
| Profits Per Employee | $51,390 |
| Employee Count | 2,400 |
| Asset Turnover | 1.96 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $19.01 million in taxes.
| Income Tax | 19.01M |
| Effective Tax Rate | 13.28% |
Stock Price Statistics
The stock price has decreased by -23.19% in the last 52 weeks. The beta is 1.86, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.86 |
| 52-Week Price Change | -23.19% |
| 50-Day Moving Average | 15.74 |
| 200-Day Moving Average | 15.10 |
| Relative Strength Index (RSI) | 41.08 |
| Average Volume (20 Days) | 37,877,324 |
Short Selling Information
The latest short interest is 62.48 million, so 24.56% of the outstanding shares have been sold short.
| Short Interest | 62.48M |
| Short Previous Month | 29.75M |
| Short % of Shares Out | 24.56% |
| Short % of Float | 30.27% |
| Short Ratio (days to cover) | 1.84 |
Income Statement
In the last 12 months, Oscar Health had revenue of $10.08 billion and earned $123.34 million in profits. Earnings per share was $0.46.
| Revenue | 10.08B |
| Gross Profit | 2.04B |
| Operating Income | 168.83M |
| Pretax Income | 23.89M |
| Net Income | 123.34M |
| EBITDA | 199.89M |
| EBIT | 168.83M |
| Earnings Per Share (EPS) | $0.46 |
Full Income StatementBalance Sheet
The company has $2.99 billion in cash and $359.08 million in debt, giving a net cash position of $1.88 billion or $7.38 per share.
| Cash & Cash Equivalents | 2.99B |
| Total Debt | 359.08M |
| Net Cash | 1.88B |
| Net Cash Per Share | $7.38 |
| Equity (Book Value) | 1.34B |
| Book Value Per Share | 5.27 |
| Working Capital | -374.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.22 billion and capital expenditures -$30.97 million, giving a free cash flow of $1.19 billion.
| Operating Cash Flow | 1.22B |
| Capital Expenditures | -30.97M |
| Free Cash Flow | 1.19B |
| FCF Per Share | $4.68 |
Full Cash Flow StatementMargins
Gross margin is 20.28%, with operating and profit margins of 1.67% and 1.22%.
| Gross Margin | 20.28% |
| Operating Margin | 1.67% |
| Pretax Margin | 1.42% |
| Profit Margin | 1.22% |
| EBITDA Margin | 1.98% |
| EBIT Margin | 1.67% |
| FCF Margin | 11.82% |
Dividends & Yields
Oscar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.35% |
| Shareholder Yield | -19.35% |
| Earnings Yield | 3.57% |
| FCF Yield | 34.49% |
Dividend DetailsAnalyst Forecast
The average price target for Oscar Health is $12.79, which is -5.82% lower than the current price. The consensus rating is "Sell".
| Price Target | $12.79 |
| Price Target Difference | -5.82% |
| Analyst Consensus | Sell |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
